George Timothy Baxley, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 220 Keowee Trl, Clemson, SC 29631 Phone: 864-653-4071 Fax: 864-653-4074 |
Dr. Jerry F Sherrill, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 101 Chapman Hill Rd, Clemson, SC 29631 Phone: 864-653-4071 |
Susan V. Breazeale, APRN Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 220 Keowee Trl, Clemson, SC 29631 Phone: 864-653-4071 Fax: 864-653-4074 |
News Archive
PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, have received a Phase I Small Business Technology Transfer (STTR) contract in the amount of $100,000 to support research to identify lead antimicrobial compounds to effectively treat multi-drug resistant and biofilm-embedded bacteria.
Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
An 84 year old was complaining of repeatedly losing his balance and falling over. He visited his primary physician in Northern Ireland from where he was referred to the emergency room. On MRI, the team of doctors found a 3½-inch pocket of air in his brain. This has never been reported before in any case and thus the detailed report titled, "The man that lost (part of) his mind," was published in the journal BMJ Case Reports.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its TransCon technology to address significant unmet medical needs, announced today that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.
› Verified 7 days ago